Athyrium Opportunities 2020 LP 13D and 13G filings for Biora Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-02 8:43 pm Purchase |
2024-03-31 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,930,628 49.900% |
309,176 (+19.07%) |
Filing |
| 2023-12-20 4:35 pm Purchase |
2023-12-18 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,621,453 49.900% |
386,569 (+31.30%) |
Filing |
| 2023-09-19 4:15 pm Purchase |
2023-09-18 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 1,234,884 49.900% |
867,926 (+236.52%) |
Filing |
| 2023-03-13 4:18 pm Purchase |
2023-03-10 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 366,958 32.700% |
82,414 (+28.96%) |
Filing |
| 2023-01-12 4:46 pm Sale |
2023-01-03 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 284,544 27.800% |
-177,555,628 (-99.84%) |
Filing |
| 2022-11-18 4:30 pm Purchase |
2022-11-09 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 177,840,173 28.400% |
10,022,310 (+5.97%) |
Filing |
| 2021-11-26 4:45 pm Purchase |
2021-11-24 | 13D | Biora Therapeutics, Inc. BIOR |
Athyrium Opportunities 2020 LP | 167,817,863 31.100% |
167,817,863 (New Position) |
Filing |